CSIMarket
 


Celgene Corp  (CELG)
Other Ticker:  
 
 

CELG's EPS Net Growth by Quarter and Year

Celgene's EPS Net results by quarter and year




CELG EPS Net (in $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 1.50 -0.10 0.53
III Quarter September 2.32 1.50 1.21 0.21
II Quarter June 2.16 1.43 1.31 0.75
I Quarter March 2.14 1.10 1.16 0.99
FY   6.62 5.53 3.58 2.48



CELG EPS Net third quarter 2019 Y/Y Growth Comment
Celgene Corp achieved in the third quarter 2019, above Company average EPS Net rise of 54.67% year on year, to $ 2.32 .

Looking into third quarter 2019 results within Major Pharmaceutical Preparations industry 6 other companies have achieved higher EPS Net growth. While Celgene Corp' s EPS Net jump of 54.67% ranks overall at the positon no. 321 in the third quarter 2019.




CELG EPS Net ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -23.19 %
III Quarter September 54.67 % 23.97 % 476.19 % -
II Quarter June 51.05 % 9.16 % 74.67 % 74.42 %
I Quarter March 94.55 % -5.17 % 17.17 % 15.12 %
FY   - 54.47 % 44.35 % 27.84 %

Financial Statements
Celgene's third quarter 2019 EPS Net $ 2.32 CELG's Income Statement
Celgene's third quarter 2018 EPS Net $ 1.50 Quarterly CELG's Income Statement
New: More CELG's historic EPS Net Growth >>


CELG EPS Net (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 0 % - 152.38 %
III Quarter September 7.41 % 4.9 % -7.63 % -72 %
II Quarter June 0.93 % 30 % 12.93 % -24.24 %
I Quarter March 42.67 % - 118.87 % 43.48 %
FY (Year on Year)   - 54.47 % 44.35 % 27.84 %




EPS Net third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #7
Healthcare Sector #25
Overall #321

EPS Net Y/Y Growth Statistics
High Average Low
476.19 % 54.03 % -84.62 %
(Sep 30 2017)   (Dec. 31, 2005)
EPS Net third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #7
Healthcare Sector #25
Overall #321
EPS Net Y/Y Growth Statistics
High Average Low
476.19 % 54.03 % -84.62 %
(Sep 30 2017)   (Dec. 31, 2005)

EPS Net by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Celgene's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
154.5 % 12.16 % -100 %
(Dec 31 2016)  


CELG's III. Quarter Q/Q EPS Net Comment
Celgene Corp achieved in the III. Quarter 2019 below company average EPS Net increase of 7.41% quarter on quarter, to $ 2.32 .

Even if the III. Quarter 2019 Celgene's results were below the ordinary of 12.16 %, it has been yet promising sign, as the III. Quarter expension, transcends the 4.9% EPS Net growth in the same quarter a year ago

Within Major Pharmaceutical Preparations industry 11 other companies have achieved higher EPS Net quarter on quarter growth. While Celgene's EPS Net growth quarter on quarter, overall rank is 931.


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #12
Healthcare Sector #64
Overall #931
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #12
Healthcare Sector #64
Overall #931
EPS Net Q/Q Growth Statistics
High Average Low
154.5 % 12.16 % -100 %
(Dec 31 2016)  


CELG's III. Quarter Q/Q EPS Net Comment
Celgene Corp achieved in the III. Quarter 2019 below company average EPS Net increase of 7.41% quarter on quarter, to $ 2.32 .

III. Quarter 2019 Celgene's EPS Net sequential growth were paradoxical, albeit lower than the ordinary, yet it shows absolute improvement measured to the 4.9% in the same quarter a year ago Alex Machado, Major Pharmaceutical Preparations industry consultant said.

Within Major Pharmaceutical Preparations industry 11 other companies have achieved higher EPS Net quarter on quarter growth. While Celgene's EPS Net growth quarter on quarter, overall rank is 931.


Celgene's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
Cumulative EPS Net 12 Months Ending $ 8.12 $ 7.30 $ 6.57 $ 5.53 $ 3.93
Y / Y EPS Net Growth (TTM) 106.62 % 100.55 % 86.65 % 54.47 % -6.75 %
Year on Year EPS Net Growth Overall Ranking # 247 # 274 # 318 # 605 # 128
Seqeuential EPS Net Change (TTM) 11.23 % 11.11 % 18.81 % 40.71 % 7.97 %
Seq. EPS Net Growth (TTM) Overall Ranking # 1012 # 469 # 431 # 413 # 199




Cumulative EPS Net growth Comment
Celgene saw improvement in EPS Net growth trend, posting cumulative 12 months EPS Net growth of 106.62% year on year, to $ 8 if the fiscal year would have ended in Sep 30 2019.
Celgene's trailing twelve months EPS Net growth was higher than company's average 48.27% and higher than 100.55% growth in Jun 30 2019.
But sequential growth rate was slower at 11.23 % from $7.3 reported in twelve months ending a quarter Jun 30 2019 Alex Machado added on.
In spite of, it was validation of strength, as the typical sequential advancement stands at -37.53%.
The growth is even stronger from twelve months ended Jun 30 2019 clinched at 11.23 % rise from $7.3 in the period from Jun 30 2019 to Sep 30 2018.

Within the Healthcare sector 33 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 247, from total ranking in previous quarter at 274.

EPS Net TTM Q/Q Growth Statistics
High Average Low
322.22 %
-37.53 %
-1378.57 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 22
Healthcare Sector # 34
Overall # 247

EPS Net TTM Y/Y Growth Statistics
High Average Low
322.22 %
48.27 %
-68.97 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 80
S&P 500 # 1012
Cumulative EPS Net growth Comment
Celgene saw improvement in EPS Net growth trend, posting cumulative 12 months EPS Net growth of 106.62% year on year, to $ 8 if the fiscal year would have ended in Sep 30 2019.
Celgene's trailing twelve months EPS Net growth was higher than company's average 48.27% and higher than 100.55% growth in Jun 30 2019.
But from twelve months ended Jun 30 2019 rise was beneth at 11.23 % from $7.3 achieved in the period from Jun 30 2019 to Sep 30 2018.
Yet it was confirmation of strength, as the usual Q/Q TTM advancement lays at -37.53%.
The growth is even stronger from the previous reporting period showed at 11.23 % rise from $7.3 in twelve months ending a quarter before.

Within the Healthcare sector 33 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 247, from total ranking in previous quarter at 274.

EPS Net TTM Q/Q Growth Statistics
High Average Low
322.22 %
-37.53 %
-1378.57 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 22
Healthcare Sector # 34
Overall # 247

EPS Net TTM Y/Y Growth Statistics
High Average Low
322.22 %
48.27 %
-68.97 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 80
S&P 500 # 1012




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
CELG's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for CELG's Competitors
EPS Net Growth for Celgene's Suppliers
EPS Net Growth for CELG's Customers

You may also want to know
CELG's Annual Growth Rates CELG's Profitability Ratios CELG's Asset Turnover Ratio CELG's Dividend Growth
CELG's Roe CELG's Valuation Ratios CELG's Financial Strength Ratios CELG's Dividend Payout Ratio
CELG's Roa CELG's Inventory Turnover Ratio CELG's Growth Rates CELG's Dividend Comparisons



Companies with similar EPS Net increase for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep 30 2019
American Renal Associates Holdings Inc 83.33%$ 83.333 
Staar Surgical Company66.67%$ 66.667 
Abbott Laboratories65.63%$ 65.625 
Orasure Technologies Inc61.54%$ 61.538 
Corcept Therapeutics Inc57.14%$ 57.143 
Celgene Corp54.67%$ 54.667 
Genomic Health Inc50.00%$ 50.000 
Carlisle Companies Incorporated46.34%$ 46.341 
Alexion Pharmaceuticals Inc 41.50%$ 41.497 
Lhc Group Inc 41.18%$ 41.176 
Quidelortho Corp40.74%$ 40.741 
Bruker Corporation39.29%$ 39.286 
Intuitive Surgical Inc 35.92%$ 35.918 
Ufp Technologies Inc 33.93%$ 33.929 
Tactile Systems Technology Inc 33.33%$ 33.333 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com